Belinostat in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery

NCT00321594 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

54

Enrollment

NIH

Sponsor class

Conditions

Adult Primary Hepatocellular Carcinoma
Advanced Adult Primary Liver Cancer
Localized Unresectable Adult Primary Liver Cancer
Recurrent Adult Primary Liver Cancer

Interventions

DRUG: belinostat

Sponsor

National Cancer Institute (NCI)